Caption Management, LLC Arbutus Biopharma Corp Transaction History
Caption Management, LLC
- $9.79 Billion
- Q1 2025
A detailed history of Caption Management, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Caption Management, LLC holds 75,000 shares of ABUS stock, worth $247,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,000
Previous 175,000
57.14%
Holding current value
$247,500
Previous $572,000
54.37%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ABUS
# of Institutions
189Shares Held
112MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$78.5 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$43.9 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.1 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$31.2 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$29.5 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $495M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...